table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Companion Diagnostic Tests
1.2 Key Market Segments
1.2.1 Companion Diagnostic Tests Segment by Type
1.2.2 Companion Diagnostic Tests Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Companion Diagnostic Tests Market Overview
2.1 Global Market Overview
2.1.1 Global Companion Diagnostic Tests Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Companion Diagnostic Tests Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Companion Diagnostic Tests Market Competitive Landscape
3.1 Global Companion Diagnostic Tests Sales by Manufacturers (2019-2024)
3.2 Global Companion Diagnostic Tests Revenue Market Share by Manufacturers (2019-2024)
3.3 Companion Diagnostic Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Companion Diagnostic Tests Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Companion Diagnostic Tests Sales Sites, Area Served, Product Type
3.6 Companion Diagnostic Tests Market Competitive Situation and Trends
3.6.1 Companion Diagnostic Tests Market Concentration Rate
3.6.2 Global 5 and 10 Largest Companion Diagnostic Tests Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Companion Diagnostic Tests Industry Chain Analysis
4.1 Companion Diagnostic Tests Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Companion Diagnostic Tests Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Companion Diagnostic Tests Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Companion Diagnostic Tests Sales Market Share by Type (2019-2024)
6.3 Global Companion Diagnostic Tests Market Size Market Share by Type (2019-2024)
6.4 Global Companion Diagnostic Tests Price by Type (2019-2024)
7 Companion Diagnostic Tests Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Companion Diagnostic Tests Market Sales by Application (2019-2024)
7.3 Global Companion Diagnostic Tests Market Size (M USD) by Application (2019-2024)
7.4 Global Companion Diagnostic Tests Sales Growth Rate by Application (2019-2024)
8 Companion Diagnostic Tests Market Segmentation by Region
8.1 Global Companion Diagnostic Tests Sales by Region
8.1.1 Global Companion Diagnostic Tests Sales by Region
8.1.2 Global Companion Diagnostic Tests Sales Market Share by Region
8.2 North America
8.2.1 North America Companion Diagnostic Tests Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Companion Diagnostic Tests Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Companion Diagnostic Tests Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Companion Diagnostic Tests Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Companion Diagnostic Tests Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 F. Hoffman LA Roche Ltd.
9.1.1 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Basic Information
9.1.2 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Overview
9.1.3 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests Product Market Performance
9.1.4 F. Hoffman LA Roche Ltd. Business Overview
9.1.5 F. Hoffman LA Roche Ltd. Companion Diagnostic Tests SWOT Analysis
9.1.6 F. Hoffman LA Roche Ltd. Recent Developments
9.2 QIAGEN, Illumina, Inc.
9.2.1 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Basic Information
9.2.2 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Overview
9.2.3 QIAGEN, Illumina, Inc. Companion Diagnostic Tests Product Market Performance
9.2.4 QIAGEN, Illumina, Inc. Business Overview
9.2.5 QIAGEN, Illumina, Inc. Companion Diagnostic Tests SWOT Analysis
9.2.6 QIAGEN, Illumina, Inc. Recent Developments
9.3 Abbott
9.3.1 Abbott Companion Diagnostic Tests Basic Information
9.3.2 Abbott Companion Diagnostic Tests Product Overview
9.3.3 Abbott Companion Diagnostic Tests Product Market Performance
9.3.4 Abbott Companion Diagnostic Tests SWOT Analysis
9.3.5 Abbott Business Overview
9.3.6 Abbott Recent Developments
9.4 Agilent Technologies, Inc.
9.4.1 Agilent Technologies, Inc. Companion Diagnostic Tests Basic Information
9.4.2 Agilent Technologies, Inc. Companion Diagnostic Tests Product Overview
9.4.3 Agilent Technologies, Inc. Companion Diagnostic Tests Product Market Performance
9.4.4 Agilent Technologies, Inc. Business Overview
9.4.5 Agilent Technologies, Inc. Recent Developments
9.5 Genomic Health, Inc.
9.5.1 Genomic Health, Inc. Companion Diagnostic Tests Basic Information
9.5.2 Genomic Health, Inc. Companion Diagnostic Tests Product Overview
9.5.3 Genomic Health, Inc. Companion Diagnostic Tests Product Market Performance
9.5.4 Genomic Health, Inc. Business Overview
9.5.5 Genomic Health, Inc. Recent Developments
9.6 BioMerieux SA, BioGenex
9.6.1 BioMerieux SA, BioGenex Companion Diagnostic Tests Basic Information
9.6.2 BioMerieux SA, BioGenex Companion Diagnostic Tests Product Overview
9.6.3 BioMerieux SA, BioGenex Companion Diagnostic Tests Product Market Performance
9.6.4 BioMerieux SA, BioGenex Business Overview
9.6.5 BioMerieux SA, BioGenex Recent Developments
9.7 AGENDIA NV
9.7.1 AGENDIA NV Companion Diagnostic Tests Basic Information
9.7.2 AGENDIA NV Companion Diagnostic Tests Product Overview
9.7.3 AGENDIA NV Companion Diagnostic Tests Product Market Performance
9.7.4 AGENDIA NV Business Overview
9.7.5 AGENDIA NV Recent Developments
9.8 Siemens Healthcare GmBH
9.8.1 Siemens Healthcare GmBH Companion Diagnostic Tests Basic Information
9.8.2 Siemens Healthcare GmBH Companion Diagnostic Tests Product Overview
9.8.3 Siemens Healthcare GmBH Companion Diagnostic Tests Product Market Performance
9.8.4 Siemens Healthcare GmBH Business Overview
9.8.5 Siemens Healthcare GmBH Recent Developments
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Basic Information
9.9.2 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Overview
9.9.3 Thermo Fisher Scientific, Inc. Companion Diagnostic Tests Product Market Performance
9.9.4 Thermo Fisher Scientific, Inc. Business Overview
9.9.5 Thermo Fisher Scientific, Inc. Recent Developments
10 Companion Diagnostic Tests Market Forecast by Region
10.1 Global Companion Diagnostic Tests Market Size Forecast
10.2 Global Companion Diagnostic Tests Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Companion Diagnostic Tests Market Size Forecast by Country
10.2.3 Asia Pacific Companion Diagnostic Tests Market Size Forecast by Region
10.2.4 South America Companion Diagnostic Tests Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Companion Diagnostic Tests by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Companion Diagnostic Tests Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Companion Diagnostic Tests by Type (2025-2030)
11.1.2 Global Companion Diagnostic Tests Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Companion Diagnostic Tests by Type (2025-2030)
11.2 Global Companion Diagnostic Tests Market Forecast by Application (2025-2030)
11.2.1 Global Companion Diagnostic Tests Sales (K Units) Forecast by Application
11.2.2 Global Companion Diagnostic Tests Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
